This inventor holds 2 USPTO granted patents. Top assignee: Aummune Ltd.. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Neria Reiss: Innovator in T-Lymphocyte Binding Aptamers
Introduction
Neria Reiss is a notable inventor based in Dolev, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of aptamers that target T-lymphocytes. His innovative work has the potential to impact various therapeutic applications.
Latest Patents
Neria Reiss holds one patent for T-lymphocyte binding aptamers. This patent provides methods and compositions that target T-lymphocytes, which are crucial components of the immune system. The development of these aptamers represents a significant advancement in targeted therapies.
Career Highlights
Neria Reiss is associated with Aummune Ltd., a company focused on innovative solutions in immunotherapy. His work at Aummune Ltd. showcases his commitment to advancing medical science through innovative research and development.
Collaborations
Neria collaborates with talented individuals such as Guy Neev and Irit Carmi-Levy. Their combined expertise contributes to the success of their projects and enhances the research environment at Aummune Ltd.
Conclusion
Neria Reiss is a pioneering inventor whose work on T-lymphocyte binding aptamers is paving the way for new therapeutic approaches. His contributions to biotechnology are noteworthy and hold promise for future advancements in the field.